E.E. Geduld’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

E.E. Geduld’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,000	Closed	-$287K	–	279
2015 Q2	$287K	Sell	2,000 -6,000	-75%	-$856K	0.18%	123
2015 Q1	$1.13M	Sell	8,000 -2,000	-20%	-$308K	0.75%	25
2014 Q4	$1.48M	Sell	10,000 -1,000	-9%	-$147K	0.8%	13
2014 Q3	$1.69M	Buy	11,000 +3,000	+38%	+$452K	1.2%	9
2014 Q2	$1.12M	Buy	+8,000	New	+$888K	0.7%	24

Other funds holding TARO

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

GCM

Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return

Think Investments San Francisco, California $847M AUM 88.1% 1-Year Est. Return

AIM

Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

MCP

Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

E.E. Geduld's TARO Position: Q3 2015 in Review

E.E. Geduld sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2015, closing a stake of 2,000 shares — an estimated $287K sold.

E.E. Geduld first reported a position in TARO in Q2 2014 and held it in 5 quarters. The position peaked at $1.69M in Q3 2014. 121 funds tracked by Wall St. Rank hold TARO as of Q3 2015.

E.E. Geduld reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2015 after selling out during the quarter.
E.E. Geduld sold 2,000 Taro Pharmaceutical Industries Ltd. shares in Q3 2015, an estimated $287K.
E.E. Geduld first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2014 and held it in 5 quarters.
E.E. Geduld's Taro Pharmaceutical Industries Ltd. position peaked at $1.69M in Q3 2014.
121 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2015.

Based on E.E. Geduld's 13F filing for Q3 2015, filed 6 Nov 2015.